PMS-CONJUGATED ESTROGENS C.S.D. TABLET

Nazione: Canada

Lingua: inglese

Fonte: Health Canada

Principio attivo:

CONJUGATED ESTROGENS

Commercializzato da:

PHARMASCIENCE INC

Codice ATC:

G03CA57

INN (Nome Internazionale):

CONJUGATED ESTROGENS

Dosaggio:

1.25MG

Forma farmaceutica:

TABLET

Composizione:

CONJUGATED ESTROGENS 1.25MG

Via di somministrazione:

ORAL

Confezione:

100/1000

Tipo di ricetta:

Prescription

Area terapeutica:

ESTROGENS

Dettagli prodotto:

Active ingredient group (AIG) number: 0106442003; AHFS:

Stato dell'autorizzazione:

CANCELLED POST MARKET

Data dell'autorizzazione:

2017-09-30

Scheda tecnica

_pms-Conjugated Estrogens CSD (tablets) _
_ _
_ _
_ _
_ page 1 of 42 _
_ _
PRODUCT MONOGRAPH
PR
PMS-CONJUGATED ESTROGENS CSD
(conjugated estrogens tablets, CSD)
0.3 mg, 0.625 mg, 0.9 mg, and 1.25 mg
ESTROGENIC HORMONES
PHARMASCIENCE INC.
DATE OF REVISION:
6111 Royalmount Avenue, Suite 100
AUGUST 28, 2009
Montreal, Quebec
H4P 2T4
CONTROL NUMBER: 120633
_pms-Conjugated Estrogens CSD (tablets) _
_ _
_ _
_ _
_ page 2 of 42 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION……………………………...
3
SUMMARY PRODUCT
INFORMATION……………………………………….3
INDICATIONS AND CLINICAL
USE…………………………………………...3
CONTRAINDICATIONS…………………………………………………………4
WARNINGS AND
PRECAUTIONS…………………………………….……….5
ADVERSE
REACTIONS………………………………………………………...13
DRUG
INTERACTIONS………………………………………………………...18
DOSAGE AND
ADMINISTRATION…………………………………………...20
OVERDOSAGE………………………………………………………………….22
ACTION AND CLINICAL
PHARMACOLOGY……………………………….23
STORAGE AND
STABILITY…………………………………………………...26
SPECIAL HANDLING
INSTRUCTIONS………………………………………26
DOSAGE FORMS, COMPOSITION AND PACKAGING……………………..26
PART II: SCIENTIFIC
INFORMATION…………………………………………….
27
PHARMACEUTICAL
INFORMATION………………………………………...27
CLINICAL
TRIALS……………………………………………………………...27
DETAILED
PHARMACOLOGY………………………………………………..32
REFERENCES…………………………………………………………………...33
PART III: CONSUMER
INFORMATION……………………………………………………
37
_pms-Conjugated Estrogens CSD (tablets) _
_ _
_